Literature DB >> 21972798

Pain in amyotrophic lateral sclerosis: a population-based controlled study.

A Chiò1, A Canosa, S Gallo, C Moglia, A Ilardi, S Cammarosano, D Papurello, A Calvo.   

Abstract

BACKGROUND AND
PURPOSE: To assess the prevalence and characteristics of pain in an epidemiological series of patients with amyotrophic lateral sclerosis (ALS) compared to population-based controls.
METHODS: Of the 183 patients with ALS resident in the province of Torino, Italy, 160 accepted to be interviewed. Controls were randomly selected from the lists of general practitioners. Pain was assessed using the Brief Pain Inventory.
RESULTS: Patients with ALS reported pain more frequently than controls [91 (56.9%) vs. 53 (33.1%); P = 0.001]. Pain frequency and intensity were correlated with a worse functional score and a longer disease duration. In patients with ALS, pain was more frequently located at the extremities (P = 0.006). Pain interfered with all areas of daily function, but patients reported a greater interference than controls in the domains of enjoyment of life and relation with other people. Sixty-four patients (70.3% of those with pain) and 24 controls (45.3% of those with pain) (P = 0.003) were treated for pain, most frequently with non-steroidal anti-inflammatory drugs. ALS cases were also more frequently prescribed non-opioid analgesics and opioids than controls.
CONCLUSIONS: Our study indicates that pain is frequent in all stages of ALS, but that it often goes underrecognized and undertreated. It is significantly more frequent in patients with ALS than in population-based controls. Future studies need to clarify the mechanisms of pain in ALS and determine the most effective treatment strategy.
© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.

Entities:  

Mesh:

Year:  2011        PMID: 21972798     DOI: 10.1111/j.1468-1331.2011.03540.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  24 in total

1.  Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.

Authors:  A Pizzimenti; M Aragona; E Onesti; M Inghilleri
Journal:  Funct Neurol       Date:  2013 Apr-May

2.  Cutaneous somatic and autonomic nerve TDP-43 deposition in amyotrophic lateral sclerosis.

Authors:  Yuting Ren; Wenxiu Liu; Yifan Li; Bo Sun; Yanran Li; Fei Yang; Hongfen Wang; Mao Li; Fang Cui; Xusheng Huang
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

3.  Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies.

Authors:  Elinor Fondell; Éilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Marjorie L McCullough; Michael J Thun; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Amyotroph Lateral Scler       Date:  2012-08-07

Review 4.  Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.

Authors:  Carlayne E Jackson; April L McVey; Stacy Rudnicki; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 5.  Supportive and symptomatic management of amyotrophic lateral sclerosis.

Authors:  Esther V Hobson; Christopher J McDermott
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

Review 6.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

7.  Natural history of muscle cramps in amyotrophic lateral sclerosis.

Authors:  James B Caress; Stephanie L Ciarlone; Elizabeth A Sullivan; Leah P Griffin; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2015-09-28       Impact factor: 3.217

Review 8.  Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Authors:  Martin R Turner
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

9.  Patient-reported problematic symptoms in an ALS treatment trial.

Authors:  Divisha Raheja; Helen E Stephens; Erik Lehman; Susan Walsh; Chengwu Yang; Zachary Simmons
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-01-29       Impact factor: 4.092

10.  Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study.

Authors:  Arianna Palmieri; Johann Roland Kleinbub; Vincenzo Calvo; Gianni Sorarù; Irene Grasso; Irene Messina; Marco Sambin
Journal:  Front Psychol       Date:  2012-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.